crystalline polymorph, composition, methods of preparing the polymorphic form of bazedoxifene acetate, treating a mammal having a disease or syndrome associated with estrogen deficiency or excess estrogen, and with abnormal proliferation or development of endometrial tissues, breast cancer in a mammal, and a postmenopausal woman for one or more vasomotor disorders, lowering cholesterol in a mammal, and inhibiting bone loss in a mammal, and, form the crystalline polymorph of bazedoxifene acetate

摘要

CRYSTALLINE POLYMORPH, COMPOSITION, METHODS OF PREPARING FOR THE BAZEDOXYPHEN ACETATE POLYMORPHIC, TREATING A MAMMER WITH A DISEASE OR SYNDROME ASSOCIATED WITH ESTROGEN DEFENSE OR EXCESSION CUT MAMMALIAN, AND A POST-MENOPAUSAL WOMAN FOR ONE OR VARIOUS VASOMOTOR DISORDERS, TO LOWER CHOLESTEROL IN A MAMMER, AND TO INHIBIT BONE LOSS IN A MAMMER, AND FORM THE CRYSTALLINE POLYMORPH OF BAZEDOXYPHYPHENE. The present invention relates to a crystalline polymorph of bazedoxifene acetate, compositions containing the same, their preparations, and their uses.